journal article·2018-01-29Open access

Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells

Liga Saulite, Karlis Pleiko, Ineta Popena, Dominyka Dapkute, Ricardas Rotomskis, Una Riekstina

Abstract

We created a 3D cell co-culture model by combining nanoengineered mesenchymal stem cells (MSCs) with the metastatic breast cancer cell line MDA-MD-231 and primary breast cancer cell line MCF7 to explore the transfer of quantum dots (QDs) to cancer cells. First, the optimal conditions for high-content QD loading in MSCs were established. Then, QD uptake in breast cancer cells was assessed after 24 h in a 3D co-culture with nanoengineered MSCs. We found that incubation of MSCs with QDs in a serum-free medium provided the best accumulation results. It was found that 24 h post-labelling QDs were eliminated from MSCs. Our results demonstrate that breast cancer cells efficiently uptake QDs that are released from nanoengineered MSCs in a 3D co-culture. Moreover, the uptake is considerably enhanced in metastatic MDA-MB-231 cells compared with MCF7 primary breast cancer cells. Our findings suggest that nanoengineered MSCs could serve as a vehicle for targeted drug delivery to metastatic cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. Jackson · Neurosurgery · 2007 · 60 · 52410.1227/01.NEU.0000255334.95532.DD ↗
2. 10.1016/j.jconrel.2014.10.01510.1016/j.jconrel.2014.10.015 ↗
3. Ramdasi · International Journal of Hematology-Oncology and Stem Cell Research · 2015 · 9 · 2
4. 10.1016/j.nano.2012.06.00310.1016/j.nano.2012.06.003 ↗
5. 10.1016/j.addr.2011.06.01010.1016/j.addr.2011.06.010 ↗
6. 10.1080/1465324060085590510.1080/14653240600855905 ↗
7. 10.3978/j.issn.2306-9759.2015.03.0110.3978/j.issn.2306-9759.2015.03.01 ↗
8. 10.1016/j.jcyt.2016.09.00310.1016/j.jcyt.2016.09.003 ↗
9. 10.1021/nn202399w10.1021/nn202399w ↗
10. Studeny · Cancer Research · 2002 · 62 · 3603
11. 10.1002/stem.18710.1002/stem.187 ↗
12. 10.4049/jimmunol.140209710.4049/jimmunol.1402097 ↗
13. 10.2147/IJN.S14336710.2147/IJN.S143367 ↗
14. 10.1089/adt.2014.57310.1089/adt.2014.573 ↗
15. 10.1016/j.tibtech.2012.12.00310.1016/j.tibtech.2012.12.003 ↗
16. 10.3389/fbioe.2016.0001210.3389/fbioe.2016.00012 ↗
17. 10.1016/j.cell.2007.08.00610.1016/j.cell.2007.08.006 ↗
18. 10.1038/srep1910310.1038/srep19103 ↗
19. 10.1177/108705710629276310.1177/1087057106292763 ↗
20. 10.1002/bit.1065510.1002/bit.10655 ↗
21. 10.1016/j.jconrel.2012.04.04510.1016/j.jconrel.2012.04.045 ↗
22. 10.1002/ijc.2752810.1002/ijc.27528 ↗
23. 10.1002/cyto.a.2222010.1002/cyto.a.22220 ↗
24. 10.1007/s12015-009-9094-910.1007/s12015-009-9094-9 ↗
25. 10.1016/j.yexcr.2013.07.02310.1016/j.yexcr.2013.07.023 ↗
26. 10.1186/s12964-016-0143-010.1186/s12964-016-0143-0 ↗
27. 10.1038/srep0907310.1038/srep09073 ↗
28. 10.1089/scd.2014.041310.1089/scd.2014.0413 ↗
29. 10.1021/nn100219810.1021/nn1002198 ↗
30. 10.1186/1472-6750-10-3610.1186/1472-6750-10-36 ↗
31. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
32. 10.1016/j.biomaterials.2013.08.03810.1016/j.biomaterials.2013.08.038 ↗
33. 10.1016/j.biomaterials.2013.10.04210.1016/j.biomaterials.2013.10.042 ↗
34. 10.1021/bm400434h10.1021/bm400434h ↗
35. 10.2147/IJN.S9454310.2147/IJN.S94543 ↗
36. 10.1155/2016/917635710.1155/2016/9176357 ↗
37. 10.1038/srep1217510.1038/srep12175 ↗
38. 10.1093/ndt/gfn06210.1093/ndt/gfn062 ↗
39. 10.1186/1746-160X-2-810.1186/1746-160X-2-8 ↗
40. 10.1002/art.2478610.1002/art.24786 ↗
41. 10.1089/ten.TEC.2009.043210.1089/ten.TEC.2009.0432 ↗
42. 10.1089/scd.2013.024910.1089/scd.2013.0249 ↗
43. 10.1186/s13287-015-0082-510.1186/s13287-015-0082-5 ↗
44. 10.1038/onc.2015.1210.1038/onc.2015.12 ↗
45. 10.7314/APJCP.2016.17.2.58110.7314/APJCP.2016.17.2.581 ↗
46. 10.1038/srep3405310.1038/srep34053 ↗
47. 10.3389/fimmu.2012.0029710.3389/fimmu.2012.00297 ↗
48. 10.1161/CIRCULATIONAHA.105.53748010.1161/CIRCULATIONAHA.105.537480 ↗
49. 10.1166/jbn.2014.173810.1166/jbn.2014.1738 ↗
50. 10.1038/nprot.2013.07610.1038/nprot.2013.076 ↗
51. 10.1038/srep3767710.1038/srep37677 ↗
52. 10.1007/s00018005032210.1007/s000180050322 ↗
53. 10.1247/csf.1202910.1247/csf.12029 ↗
54. 10.3762/bjnano.8.12310.3762/bjnano.8.123 ↗